From single gene analysis to single cell profiling: a new era for precision medicine
Open Access
- 5 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Experimental & Clinical Cancer Research
- Vol. 39 (1), 1-11
- https://doi.org/10.1186/s13046-020-01549-3
Abstract
Molecular profiling of DNA and RNA has provided valuable new insights into the genetic basis of non-malignant and malignant disorders, as well as an increased understanding of basic mechanisms that regulate human disease. Recent technological advances have enabled the analyses of alterations in gene-based structure or function in a comprehensive, high-throughput fashion showing that each tumor type typically exhibits distinct constellations of genetic alterations targeting one or more key cellular pathways that regulate cell growth and proliferation, evasion of the immune system, and other aspects of cancer behavior. These advances have important implications for future research and clinical practice in areas as molecular diagnostics, the implementation of gene or pathway-directed targeted therapy, and the use of such information to drive drug discovery. The 1st international and 32nd Annual Conference of Italian Association of Cell Cultures (AICC) conference wanted to offer the opportunity to match technological solutions and clinical needs in the era of precision medicine.Keywords
This publication has 48 references indexed in Scilit:
- Cancer immunotherapy: harnessing the immune system to battle cancerJCI Insight, 2015
- Tumor-intrinsic oncogene pathways mediating immune avoidanceOncoImmunology, 2015
- ZNF281 contributes to the DNA damage response by controlling the expression of XRCC2 and XRCC4Oncogene, 2015
- Systems Biology Approach for Cancer Vaccine Development and EvaluationVaccines, 2015
- Real-time resolution of point mutations that cause phenovariance in miceProceedings of the National Academy of Sciences of the United States of America, 2015
- Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survivalCarcinogenesis: Integrative Cancer Research, 2014
- Mesothelioma: closer to the target?The Lancet Oncology, 2013
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- In VivoPersistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)Cancer Research, 2011
- The immunologic constant of rejectionTrends in Immunology, 2008